Abstract
The compilation of this HTA followed predefined steps to ensure the quality of process and results. The procedure was based on the commission documents provided and the generally accepted international guidelines for the compilation of HTA reports, as well as on the special requirements set by the ‘Complementary Medicine Evaluation Programme’ (PEK) in Switzerland (ECHTA 2001, BSV 2001, DIMDI 2004, INHTA 2001, Heusser 2001).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bundesamt für Sozialversicherung der Schweiz (ed. now: Bundesamt für Gesundheit BAG) (1996 and 2002) Handbuch zur Standardisierung der medizinischen und wirtschaftlichen Bewertung medizinischer Leistungen. Bern
Busse R, Orvain J, Drummond M, Gurtner F, Jørgensen T, Jovell A, Malone J, Perleth M, Wild C (2001) Best practice in undertaking and reporting HTA. ECHTA Working Group 4 Final Report July 2001. available at: http://www.oeaw.ac.at/ita/ebene5/WG4_FinalReport_010719.pdf
Chalmers TC, Smith H jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A (1981) A method for assessing the quality of a randomized control trial. Control Clin Trials 2:31–49
The Cochrane Collaboration (2001) Cochrane Reviewers Handbook. Handbook 4.1.4.
Deutsche Agentur für Health Technology Assessment (DAHTA) beim Deutschen Institut für medizinische Information und Dokumentation (DIMDI) (2004) HTA: Vorgehensweise, Konzept und Inhalt. Available at: http://wwwdimdide/de/hta/hta_dimdi/Konzepthtml.
Glanville J, Sowden A. Identification of the need for a review. In: Khan K, ter Riet G, Glanville J, Sowden A, Kleijnen J (eds) (2001) Undertaking systematic reviews of research on effectiveness. CRD Report Number 4 (2nd edn), York
Heusser P (1999) Probleme von Studiendesigns mit Randomisation, Verblindung und Placebogabe. Forschende Komplementärmedizin 6:89–102
Heusser P (2001) Criteria for assessing benefit with complementary medical methods. [in German]. Forschende Komplementärmedizin und Klassische Naturheilkunde 8:14–23
International Network of Agencies for Health Technology Assessments (INAHTA) (2001) A Checklist for Health Technology Assessment Reports. http://www.dimdi.de/de/hta/hta_dimdi/inahtachecklist.pdf
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuy HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
Linde K, Hondras M, Vickers A, ter Riet G, Melchart D (2001) Systematic reviews of complementary therapies – an annotated bibliography. Part 3: Homeopathy. BMC Complement Alternat Med 1:4
NHS Centre for Reviews and Dissemination, Kleijnen J et al. Undertaking systematic reviews of research on effectiveness. CRD Report No 4.CRD Publications. Available at: http://www.york.ac.uk/inst/crd/report4.htm
Wein C (2002) Qualitätsaspekte klinischer Studien zur Homöopathie. KVC, Essen
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Maxion-Bergemann, S., Bornhöft, G., Wolf, U. (2011). HTA Homeopathy: Methods and Material. In: Bornhöft, G., Matthiessen, P.F. (eds) Homeopathy in Healthcare – Effectiveness, Appropriateness, Safety, Costs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20638-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-20638-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20637-5
Online ISBN: 978-3-642-20638-2
eBook Packages: MedicineMedicine (R0)